NCT05545826

Vibrotactile Coordinated Reset (VCR): A Treatment for Early Stage Parkinson's Disease

Vibrotactile Coordinated Reset: A Treatment for Early Stage Parkinson's Disease

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Stanford University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on early stage Parkinson's symptoms. VCR will be administered with a device called the Stanford Glove. vCR is expected to provide patients with a non-invasive alternative to the most widely used treatments such as levodopa and or deep brain stimulation. Patients will be followed for two years.

Conditions

• Parkinson Disease

Interventions

Type	Name	Description
DEVICE	Vibrotactile coordinated reset	The purpose of this study is to test the efficacy of vibrotactile coordinated reset stimulation on human subject participants with early stage Parkinson's disease

Timeline

• Start date: 2025-04-01
• Primary completion: 2027-10-20
• Completion: 2027-10-20
• First posted: 2022-09-19
• Last updated: 2024-08-19

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study